Table 2.
Laboratory values of patients before and after IMiDs
| Thalidomide | Lenalidomide | |
|---|---|---|
| Before treatment | ||
| Hb* | 11.6 | 11.9 |
| Htc* | 34.8 | 35.9 |
| WBC* | 4.58 | 6.44 |
| Plt* | 182 | 209 |
| 1st month | ||
| Hb | 11.5 | 11.6 |
| Htc | 35.2 | 35.2 |
| WBC | 4.43 | 5.58 |
| Plt | 197 | 205 |
| 2nd month | ||
| Hb | 11.8 | 11.6 |
| Htc | 35.2 | 35.1 |
| WBC | 4.65 | 5.21 |
| Plt | 212 | 172 |
| 3rd month | ||
| Hb | 12.0 | 11.5 |
| Htc | 36.2 | 34.4 |
| WBC | 4.73 | 4.56 |
| Plt | 212 | 169 |
*Hb g/dL, *Htc%, *WBC mm9, *Plt mm9.